Grant Schemes – PharmAlliance

Each School recognizes that strategic investment is required to accelerate collaborations and achieve PharmAlliance objectives and priorities. Funding is intended to support the planning and development of education, practice/professional engagement, or research projects/programs consistent with the PharmAlliance mission.

PharmAlliance Research Clusters for Doctoral Training (PARCDT)

PA Research Clusters for Doctoral Training 2024 Posted Download

PharmAlliance has historically sought to stimulate research collaborations via support for joint research programs across two or three schools for investigator-driven projects. These programs have helped promote collaborations and have generated some external funding applications. In an effort to simultaneously stimulate collaborations in graduate education and research, the Partnership has moved to an alternate method of support based on the three key principles outlined below:

To support research in targeted research areas of impact: Artificial Intelligence (AI) and social impact encompassing climate health, pandemic preparedness, and medication safety
To support PhD student scholarships rather than postdoctoral or research assistant positions
To ‘cluster’ support within a priority area to provide a linked cohort of PharmAlliance PhD students

We invite you to consider applying for funding via this new approach. Please note the following important dates:

30 September 2024 – Accepting applications
28 February 2025 – Applications due
28 March 2025 – Award announcement
31 March 2025 – Funding available

For an overview of current PARCDT projects and their outcomes, click here to view presentations at PharmAlliance Week 2024.

Early Career Researcher (ECR) Award

ECR Award Application_2025 Posted Download

PharmAlliance is committed to the support of early career researcher (ECR) career development and to acceleration of research activities in our priority areas. We are now soliciting requests for PharmAlliance Early Career Researcher (ECR) Award applications. Proposed use of funds must benefit at least two of the three PharmAlliance institutions. Though not a requirement, contribution to PharmAlliance priority areas will be viewed favourably in applications.

The award amount requested should reflect the actual cost of the activities, and should not exceed USD $10,000. Awards may be used to support the following:

Travel – funds may be used to cover travel costs to meet PharmAlliance collaborators to plan or progress a project or learn a technique/skill.
Research Activities – funds may be used to purchase supplies or services required to progress a collaborative project.
Other – With appropriate justification, requests can be made for alternative uses of award funds.

Eligibility:

The awardee must be an ECR, however other participants in the application do not need to be ECRs.
- An ECR is defined as an academic researcher who has completed their terminal degree or end of post-graduate clinical training – whichever date is later – within the past 10 years, AND who has not received a major independent research award (>USD $250,000) as a principal investigator.
- Note – ECRs can apply for both their own award AND as an “other participant”.
The awardee must have participated as a presenter in at least one PharmAlliance event. If an applicant has not yet presented in a PharmAlliance event, they must be scheduled to present in an upcoming event. The following events meet this criteria: PharmAlliance Week, ECR Showcase, Visiting Scholar seminar, Graduate Research E-Symposium (if the ECR participated in this event as a moderator OR previously as a student).
The awardee must be willing to provide a written and/or oral progress report, to be made available within the PharmAlliance partnership, within 6-12 months of project start date. If possible, oral progress reports will be presented at PharmAlliance Week (virtual or in-person).